Skip to content

LivaNova LIVN Gross Profit

Gross Profit at other companies

Abbott logo
AbbottABT
$6.27B+6.5%
Haemonetics logo
HaemoneticsHAE
$198.21M+2.7%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
Stryker logo
StrykerSYK
$3.81B+1.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$184.8M+7.4%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's gross profit?
LivaNova (LIVN) reported gross profit of $243.75M in Q1 2026.
How has LivaNova's gross profit changed year-over-year?
LivaNova's gross profit increased by 12.7% year-over-year, from $216.25M to $243.75M.
What is the long-term trend for LivaNova's gross profit?
Over 4 years (2021 to 2025), LivaNova's gross profit has grown at a 7.4% compound annual growth rate (CAGR), from $705.99M to $939.87M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.